Health Canada drug identification number

DIN 02241089 — GADOVIST 1.0 604.72 MG

GADOVIST 1.0 is a solution of Gadobutrol marketed by BAYER INC. The full Gadobutrol monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02241089
Brand name
GADOVIST 1.0
Active ingredient
Gadobutrol
Strength
604.72 MG
Dosage form
SOLUTION
Route
INTRAVENOUS
Manufacturer
BAYER INC
Health Canada status
MARKETED
Drug class
Macrocyclic gadolinium-based contrast agent (MRI contrast)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Gadobutrol products

DINBrandStrengthFormManufacturerStatus
02553678 PIXXOSCAN 604.72 MG SOLUTION GE HEALTHCARE CANADA INC MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.